CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schuetz, J. D.
Right arrow Articles by Schuetz, E. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schuetz, J. D.
Right arrow Articles by Schuetz, E. G.

Cell Growth & Differentiation, Vol 6, Issue 10 1321-1332, Copyright © 1995 by American Association of Cancer Research


ARTICLES

Divergent regulation of the class II P-glycoprotein gene in primary cultures of hepatocytes versus H35 hepatoma by glucocorticoids

JD Schuetz, JA Silverman, JV Thottassery, KN Furuya and EG Schuetz
Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee 38105-2794, USA.

We investigated whether the glucocorticoid-mediated mechanisms controlling P-glycoprotein (pgp2 or mdr1b) are similar in normal hepatocytes compared with the H35 hepatoma cell line. In primary rat hepatocytes, dexamethasone (DEX) caused a dose- and time-dependent decrease in the amount of the pgp2 mRNA, which correlated with functional pgp2 expression (intracellular accumulation of [3H]vincristine). The suppression of pgp2 mRNA was specific for glucocorticoids because a representative estrogen and progestin were without effect, and DEX suppression of pgp2 mRNA could be reversed by cotreatment with an anti-glucocorticoid. DEX suppression of pgp2 mRNA appears to be posttranscriptional because following actinomycin D inhibition of new RNA synthesis, the pgp2 transcript disappeared at a faster rate in DEX treated versus untreated hepatocytes. Moreover, transcriptional activity of chloramphenicol acetyltransferase plasmids containing the pgp2 promoter in primary rat hepatocytes was unaffected by DEX treatment. Thus, suppression of pgp2 mRNA by glucocorticoids in primary hepatocytes is due to a decrease in pgp2 mRNA stability. In contrast, in the H35 hepatoma cell line, DEX dose dependently increased pgp protein and pgp2 mRNA, effects which parallel transcriptional activation of the pgp2 promoter. Activation of the pgp2 promoter was specific for glucocorticoids since a representative estrogen had no significant effect on transcription of the pgp2 promoter and RU486 blocked DEX activation of pgp2 transcription. Transcriptional activation of the pgp2 promoter was not due to a global up-regulation of basal transcription factors because DEX treatment did not activate either a herpes simplex virus thymidine kinase promoter or the SV40 early gene promoter. Further studies with a panel of pgp2 5' sequence deletion plasmids revealed that the minimal promoter (-66 bp) was not activated by DEX. In contrast, inclusion of sequences up to -177 bp restored DEX-dependent transcriptional activation. These are the first studies to demonstrate that glucocorticoids regulate pgp2 by different mechanisms in normal rat hepatocytes compared to the H35 hepatoma cell line.


This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
Y. Hayashi, K. Ushijima, H. Ando, H. Yanagihara, E. Ishikawa, S.-i. Tsuruoka, K.-i. Sugimoto, and A. Fujimura
Influence of a Time-Restricted Feeding Schedule on the Daily Rhythm of abcb1a Gene Expression and Its Function in Rat Intestine
J. Pharmacol. Exp. Ther., November 1, 2010; 335(2): 418 - 423.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
V. S. Narang, C. Fraga, N. Kumar, J. Shen, S. Throm, C. F. Stewart, and C. M. Waters
Dexamethasone increases expression and activity of multidrug resistance transporters at the rat blood-brain barrier
Am J Physiol Cell Physiol, August 1, 2008; 295(2): C440 - C450.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Kishi, W. Yang, B. Boureau, S. Morand, S. Das, P. Chen, E. H. Cook, G. L. Rosner, E. Schuetz, C.-H. Pui, et al.
Effects of prednisone and genetic polymorphisms on etoposide disposition in children with acute lymphoblastic leukemia
Blood, January 1, 2004; 103(1): 67 - 72.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
P. P. Annaert, R. Z. Turncliff, C. L. Booth, D. R. Thakker, and K. L. R. Brouwer
P-Glycoprotein-Mediated In Vitro Biliary Excretion in Sandwich-Cultured Rat Hepatocytes
Drug Metab. Dispos., October 1, 2001; 29(10): 1277 - 1283.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
K. Lange and J. Gartzke
Microvillar cell surface as a natural defense system against xenobiotics: a new interpretation of multidrug resistance
Am J Physiol Cell Physiol, August 1, 2001; 281(2): C369 - C385.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
V. Lecureur, D. Sun, P. Hargrove, E. G. Schuetz, R. B. Kim, L.-B. Lan, and J. D. Schuetz
Cloning and Expression of Murine Sister of P-Glycoprotein Reveals a More Discriminating Transporter Than MDR1/P-Glycoprotein
Mol. Pharmacol., January 1, 2000; 57(1): 24 - 35.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
J. V. Thottassery, D. Sun, G. P. Zambetti, A. Troutman, V. P. Sukhatme, E. G. Schuetz, and J. D. Schuetz
Sp1 and Egr-1 Have Opposing Effects on the Regulation of the RatPgp2/mdr1b Gene
J. Biol. Chem., January 29, 1999; 274(5): 3199 - 3206.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. V. Thottassery, G. P. Zambetti, K. Arimori, E. G. Schuetz, and J. D. Schuetz
p53-dependent regulation of MDR1 gene expression causes selective resistance to chemotherapeutic agents
PNAS, September 30, 1997; 94(20): 11037 - 11042.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
K. N. Furuya, J. V. Thottassery, E. G. Schuetz, M. Sharif, and J. D. Schuetz
Bromocriptine Transcriptionally Activates the Multidrug Resistance Gene (pgp2/mdr1b) by a Novel Pathway
J. Biol. Chem., April 25, 1997; 272(17): 11518 - 11525.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1995 by the American Association of Cancer Research.